A diabody that dissociates to monomer forms at low concentration: effects on binding activity and tumor targeting
- 25 February 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 327 (4) , 999-1005
- https://doi.org/10.1016/j.bbrc.2004.12.114
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Single Treatment of Yttrium-90-labeled CHX-A″–C6.5 Diabody Inhibits the Growth of Established Human Tumor Xenografts in Immunodeficient MiceCancer Research, 2004
- A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cellsBiochemical and Biophysical Research Communications, 2004
- Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapyGene Therapy, 2003
- The Crystal Structure of an Anti-CEA scFv Diabody Assembled from T84.66 scFvs in VL-to-VH Orientation: Implications for Diabody FlexibilityJournal of Molecular Biology, 2003
- Reversible Dimer Formation and Stability of the Anti-tumour Single-chain Fv Antibody MFE-23 by Neutron Scattering, Analytical Ultracentrifugation, and NMR and FT-IR SpectroscopyJournal of Molecular Biology, 2002
- Different Equilibrium Stability Behavior of ScFv Fragments: Identification, Classification, and Improvement by Protein EngineeringBiochemistry, 1999
- Factors Influencing the Dimer to Monomer Transition of an Antibody Single-Chain Fv FragmentBiochemistry, 1998
- Redesigned anti-human placental alkaline phosphatase single-chain Fv: soluble expression, characterization and in vivo tumour targetingProtein Engineering, Design and Selection, 1997
- Preparation of a Bispecific F(ab')2 Targeted to the Human IL-2 ReceptorJournal of Hematotherapy, 1995
- Crystal structure of a diabody, a bivalent antibody fragmentStructure, 1994